Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) HKSE

97.15

+1.45(+1.52%)

Updated at September 08 11:28AM

Currency In HKD

Asymchem Laboratories (Tianjin) Co., Ltd.

Address

No. 6 Dongting 3rd Street

Tianjin,

China

Phone

N/A

Sector

Healthcare

Industry

Biotechnology

Employees

9595

First IPO Date

December 10, 2021

Key Executives

NameTitlePayYear Born
Dr. Hao Hong Ph.D.Founder, Chairman & Chief Executive Officer01956
Ms. Rui YangCo-Chief Executive Officer & Executive Director01977
Mr. Da ZhangChief Financial Officer, Chief Operating Officer, Senior Vice President & Executive Director01981
Dr. Xinhui Hu Ph.D.Chief Technology Officer & Chief Commercial Officer01973
Mr. Xiangke XuSenior Vice President & Company Secretary01979
Ms. Elut HsuPresident & GM0N/A
Dr. Liang HongSenior Vice President of Process Development & Application and Executive Director01974
Mr. Chaoyong ChenSenior Vice President of Resource & Development01982
Mr. Jiang YingweiSenior Vice President of Human Resources01977
Dr. Yan ZhouSenior Vice President01979

Description

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.